These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9329697)

  • 1. Clinical studies of cerebral blood flow in Alzheimer's disease.
    Jagust WJ; Eberling JL; Reed BR; Mathis CA; Budinger TF
    Ann N Y Acad Sci; 1997 Sep; 826():254-62. PubMed ID: 9329697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease.
    Wolfe N; Reed BR; Eberling JL; Jagust WJ
    Arch Neurol; 1995 Mar; 52(3):257-62. PubMed ID: 7872878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced temporal lobe blood flow in Alzheimer's disease.
    Eberling JL; Jagust WJ; Reed BR; Baker MG
    Neurobiol Aging; 1992; 13(4):483-91. PubMed ID: 1508299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease.
    Sabbagh MN; Lynn P; Jhingran S; Massman P; Villanueva-Meyer J; Olup J; Doody RS
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):68-74. PubMed ID: 9017531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function and regional cerebral blood flow in Parkinson's disease.
    Jagust WJ; Reed BR; Martin EM; Eberling JL; Nelson-Abbott RA
    Brain; 1992 Apr; 115 ( Pt 2)():521-37. PubMed ID: 1606480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial mini-mental state and cerebral perfusion in Alzheimer's disease.
    Ones T; Midi I; Dede F; Tuncer N; Erdil TY; Onultan O; Ceylan S; Inanir S; Turoglu HT
    Clin Neuroradiol; 2012 Sep; 22(3):219-26. PubMed ID: 22212925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and
    Yoshida T; Mori T; Shimizu H; Yoshino Y; Sonobe N; Matsumoto T; Kikuchi K; Miyagawa M; Iga J; Mochizuki T; Ueno SI
    Int J Geriatr Psychiatry; 2017 Apr; 32(4):407-413. PubMed ID: 27094214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.
    Staffen W; Schönauer U; Zauner H; Spindler I; Mair A; Iglseder B; Bernroider G; Ladurner G
    J Neural Transm (Vienna); 2006 Feb; 113(2):195-203. PubMed ID: 15959843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Event-related potential prolongation in Alzheimer's disease signifies frontal lobe impairment: evidence from SPECT imaging.
    O'Mahony D; Coffey J; Murphy J; O'Hare N; Hamilton D; Rowan M; Freyne P; Walsh JB; Coakley D
    J Gerontol A Biol Sci Med Sci; 1996 May; 51(3):M102-7. PubMed ID: 8630702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment.
    Cappa A; Calcagni ML; Villa G; Giordano A; Marra C; De Rossi G; Puopolo M; Gainotti G
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):22-7. PubMed ID: 11118243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
    Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
    Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity.
    DeKosky ST; Shih WJ; Schmitt FA; Coupal J; Kirkpatrick C
    Alzheimer Dis Assoc Disord; 1990; 4(1):14-23. PubMed ID: 2317335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease.
    Hanaoka T; Kimura N; Aso Y; Takemaru M; Kimura Y; Ishibashi M; Matsubara E
    Geriatr Gerontol Int; 2016 Jul; 16(7):836-42. PubMed ID: 26245516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Cerebral Perfusion in Alzheimer Patients and First-Degree Relatives: Lessons from Artemisa Province, Cuba.
    Peña-Quián Y; Sosa-Pérez S; Batista-Cuéllar JF; Rodríguez-Tanty C; Torres-Aroche LA; Luz-Sánchez E; Romero-Collado S
    MEDICC Rev; 2021 Jan; 23(1):55-63. PubMed ID: 33780424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.